Our core differentiator is access to hard-to-reach populations, particularly rare disease patients and specialist physicians. In fact, we have built our network specifically to support rare and ultra-rare conditions, where traditional research panels often have little or no coverage. As a result, we are able to identify highly relevant participants more efficiently.

Furthermore, every participant’s diagnosis is carefully verified before they join a study. Therefore, clients can rely on the accuracy, quality, and integrity of the data collected.

Our clients include pharmaceutical and biotechnology companies, contract research organizations (CROs), healthcare consultancies, HEOR teams, medical device companies, and patient advocacy organizations. In addition, we support a wide range of research needs across the healthcare sector. For example, our studies span from early clinical development to post-launch market assessment. As a result, we provide valuable insights at every stage of the product lifecycle.

MedPanel is headquartered in Groton, Massachusetts, USA. However, we conduct research on a global scale, ensuring broad access to diverse patient populations. In addition, we follow GDPR-compliant processes for European studies while maintaining localized recruitment expertise in key international markets. As a result, we deliver consistent, high-quality research across regions.